跳至主要内容
临床试验/NCT03687060
NCT03687060Unknown不适用

Behavioral Economics and Implementation Research to Reduce Cardiovascular Risk in HIV-Infected Adults

University of California, Los Angeles8 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2019年3月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
75
试验地点
8
主要终点
Change in proportion of PLWH with cardiovascular risk factors seen by a physician receiving statin therapy

研究概览

简要总结

Cardiovascular disease is a major cause of morbidity and mortality among people living with HIV. Recent studies have demonstrated that patients with HIV experience a 50-100% increased risk of myocardial infarction and stroke compared to HIV-uninfected persons. They also face higher risks of stroke, sudden death, and heart failure. However, evidence-based statin therapy-which is safe in this population and highly effective at reducing cardiovascular risk-is under-prescribed. The investigators propose a multi-level intervention to increase evidence-based statin prescribing by addressing barriers at these levels. The implementation intervention includes two strategies: (1) tailored education at the leadership, provider, and patient levels, and (2) behavioral economics-informed feedback for providers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •age ≥ 40 years
  • •have been diagnosed with HIV
  • •LDL ≥ 190, diabetes and LDL ≥ 70
  • •or 10-year ASCVD risk ≥ 7.5%
  • •or history of heart attack, stroke, or peripheral vascular disease
  • •care for patients with HIV at least 1/2 day each week (physicians)
  • •work at participating clinics (physicians)

排除标准

  • •unable to provide written, informed consent
  • •not at participating clinic

研究组 & 干预措施

Patient Level

Other

干预措施: Knowledge assessment (Behavioral)

Organization Level

Other

干预措施: Knowledge assessment (Behavioral)

Provider Level

Other

干预措施: Knowledge assessment (Behavioral)

Provider Level

Other

干预措施: Education Intervention (Behavioral)

Provider Level

Other

干预措施: Provider Feedback (Behavioral)

结局指标

主要结局

Change in proportion of PLWH with cardiovascular risk factors seen by a physician receiving statin therapy

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Allison L. Diamant

Principal Investigator

University of California, Los Angeles

研究点 (8)

Loading locations...

相似试验

INcreasing Statin Prescribing in HIV Behavioral... | 临床试验